Two L-nucleosides, L-30-amino-30-deoxy-N6-dimethyladenosine (L-30-ADMdA) 1, previously synthesized in our laboratory, and the novel L-30-amino-30-deoxy-N6-methyladenosine-50-N-methyluronamide (L-30-AM-MECA) 2 were evaluated in an ischemia/reperfusion model on Langendorff perfused mouseheart. L-30-ADMdA 1 was found to enhance functional recovery from ischemia (32.2 ± 3.7 cm H2O/s % ratepressure product, compared to 21.3 ± 1.4 for the control and 30.7 ± 3.4 for adenosine) and increase the time to onset of ischemic contracture (14.5 ± 0.9 min, compared to 10.5 ± 1.0 min for the control and 13.6 ± 0.6 min for adenosine) comparable to adenosine. Consistent with the functional recovery data,decreased infarction area was seen in the case of 1 (19.1 ± 8.4, compared to 40.5 ± 7.2% for the control and 11.5 ± 2.1% for adenosine). In contrast, L-30-AM-MECA 2 did not show significant functional recovery,increased onset of contracture, nor decreased infarction area compared to control. Unlike adenosine,neither 1 nor 2 induced cardiac standstill in mouse heart.
Novel L-adenosine analogs as cardioprotective agents
CHIACCHIO M;
2009-01-01
Abstract
Two L-nucleosides, L-30-amino-30-deoxy-N6-dimethyladenosine (L-30-ADMdA) 1, previously synthesized in our laboratory, and the novel L-30-amino-30-deoxy-N6-methyladenosine-50-N-methyluronamide (L-30-AM-MECA) 2 were evaluated in an ischemia/reperfusion model on Langendorff perfused mouseheart. L-30-ADMdA 1 was found to enhance functional recovery from ischemia (32.2 ± 3.7 cm H2O/s % ratepressure product, compared to 21.3 ± 1.4 for the control and 30.7 ± 3.4 for adenosine) and increase the time to onset of ischemic contracture (14.5 ± 0.9 min, compared to 10.5 ± 1.0 min for the control and 13.6 ± 0.6 min for adenosine) comparable to adenosine. Consistent with the functional recovery data,decreased infarction area was seen in the case of 1 (19.1 ± 8.4, compared to 40.5 ± 7.2% for the control and 11.5 ± 2.1% for adenosine). In contrast, L-30-AM-MECA 2 did not show significant functional recovery,increased onset of contracture, nor decreased infarction area compared to control. Unlike adenosine,neither 1 nor 2 induced cardiac standstill in mouse heart.File | Dimensione | Formato | |
---|---|---|---|
BiorMedChem2009.pdf
solo gestori archivio
Licenza:
Non specificato
Dimensione
241.16 kB
Formato
Adobe PDF
|
241.16 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.